There are multiple drugs in the pipeline for opioid induced constipation treatment. Upon approval, these drugs will face little competition in this market which is largely untapped. There have not been many stable choices in the pharmaceutical industry for opioid induced constipation treatment over the recent past, but the continuous approval rate of highly targeted drugs is expected to provide a strong push to this market’s growth rate.
Market Analysis and Insights: Global Opioid Induced Constipation Treatment Market
The global Opioid Induced Constipation Treatment market size is projected to reach US$ 1164.2 million by 2026, from US$ 981.8 million in 2020, at a CAGR of 17.7%% during 2021-2026.
Global Opioid Induced Constipation Treatment Scope and Market Size
Opioid Induced Constipation Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Opioid Induced Constipation Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The following players are covered in this report:
GlaxoSmithKline
AstraZeneca
Pfizer
S.L.A. Pharma
AIKO Biotechnology
Cubist Pharmaceuticals
Salix Pharmaceuticals
Takeda Pharmaceutical
Opioid Induced Constipation Treatment Breakdown Data by Type
Oral
Parenteral (Subcutaneous Injection)
Opioid Induced Constipation Treatment Breakdown Data by Application
Drug Store
Independent Pharmacies
Hospital Pharmacies
Market Analysis and Insights: Global Opioid Induced Constipation Treatment Market
The global Opioid Induced Constipation Treatment market size is projected to reach US$ 1164.2 million by 2026, from US$ 981.8 million in 2020, at a CAGR of 17.7%% during 2021-2026.
Global Opioid Induced Constipation Treatment Scope and Market Size
Opioid Induced Constipation Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Opioid Induced Constipation Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The following players are covered in this report:
GlaxoSmithKline
AstraZeneca
Pfizer
S.L.A. Pharma
AIKO Biotechnology
Cubist Pharmaceuticals
Salix Pharmaceuticals
Takeda Pharmaceutical
Opioid Induced Constipation Treatment Breakdown Data by Type
Oral
Parenteral (Subcutaneous Injection)
Opioid Induced Constipation Treatment Breakdown Data by Application
Drug Store
Independent Pharmacies
Hospital Pharmacies
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Opioid Induced Constipation Treatment Revenue
1.4 Market by Type
1.4.1 Global Opioid Induced Constipation Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Oral
1.4.3 Parenteral (Subcutaneous Injection)
1.5 Market by Application
1.5.1 Global Opioid Induced Constipation Treatment Market Share by Application: 2020 VS 2026
1.5.2 Drug Store
1.5.3 Independent Pharmacies
1.5.4 Hospital Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Opioid Induced Constipation Treatment Market Perspective (2015-2026)
2.2 Global Opioid Induced Constipation Treatment Growth Trends by Regions
2.2.1 Opioid Induced Constipation Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Opioid Induced Constipation Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Opioid Induced Constipation Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Opioid Induced Constipation Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Opioid Induced Constipation Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Opioid Induced Constipation Treatment Players by Market Size
3.1.1 Global Top Opioid Induced Constipation Treatment Players by Revenue (2015-2020)
3.1.2 Global Opioid Induced Constipation Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Opioid Induced Constipation Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Opioid Induced Constipation Treatment Market Concentration Ratio
3.2.1 Global Opioid Induced Constipation Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Opioid Induced Constipation Treatment Revenue in 2019
3.3 Opioid Induced Constipation Treatment Key Players Head office and Area Served
3.4 Key Players Opioid Induced Constipation Treatment Product Solution and Service
3.5 Date of Enter into Opioid Induced Constipation Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Opioid Induced Constipation Treatment Historic Market Size by Type (2015-2020)
4.2 Global Opioid Induced Constipation Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Opioid Induced Constipation Treatment Market Size by Application (2015-2020)
5.2 Global Opioid Induced Constipation Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Opioid Induced Constipation Treatment Market Size (2015-2020)
6.2 Opioid Induced Constipation Treatment Key Players in North America (2019-2020)
6.3 North America Opioid Induced Constipation Treatment Market Size by Type (2015-2020)
6.4 North America Opioid Induced Constipation Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Opioid Induced Constipation Treatment Market Size (2015-2020)
7.2 Opioid Induced Constipation Treatment Key Players in Europe (2019-2020)
7.3 Europe Opioid Induced Constipation Treatment Market Size by Type (2015-2020)
7.4 Europe Opioid Induced Constipation Treatment Market Size by Application (2015-2020)
8 China
8.1 China Opioid Induced Constipation Treatment Market Size (2015-2020)
8.2 Opioid Induced Constipation Treatment Key Players in China (2019-2020)
8.3 China Opioid Induced Constipation Treatment Market Size by Type (2015-2020)
8.4 China Opioid Induced Constipation Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Opioid Induced Constipation Treatment Market Size (2015-2020)
9.2 Opioid Induced Constipation Treatment Key Players in Japan (2019-2020)
9.3 Japan Opioid Induced Constipation Treatment Market Size by Type (2015-2020)
9.4 Japan Opioid Induced Constipation Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Opioid Induced Constipation Treatment Market Size (2015-2020)
10.2 Opioid Induced Constipation Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Opioid Induced Constipation Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Opioid Induced Constipation Treatment Market Size by Application (2015-2020)
11 India
11.1 India Opioid Induced Constipation Treatment Market Size (2015-2020)
11.2 Opioid Induced Constipation Treatment Key Players in India (2019-2020)
11.3 India Opioid Induced Constipation Treatment Market Size by Type (2015-2020)
11.4 India Opioid Induced Constipation Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Opioid Induced Constipation Treatment Market Size (2015-2020)
12.2 Opioid Induced Constipation Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Opioid Induced Constipation Treatment Market Size by Type (2015-2020)
12.4 Central & South America Opioid Induced Constipation Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 GlaxoSmithKline
13.1.1 GlaxoSmithKline Company Details
13.1.2 GlaxoSmithKline Business Overview
13.1.3 GlaxoSmithKline Opioid Induced Constipation Treatment Introduction
13.1.4 GlaxoSmithKline Revenue in Opioid Induced Constipation Treatment Business (2015-2020))
13.1.5 GlaxoSmithKline Recent Development
13.2 AstraZeneca
13.2.1 AstraZeneca Company Details
13.2.2 AstraZeneca Business Overview
13.2.3 AstraZeneca Opioid Induced Constipation Treatment Introduction
13.2.4 AstraZeneca Revenue in Opioid Induced Constipation Treatment Business (2015-2020)
13.2.5 AstraZeneca Recent Development
13.3 Pfizer
13.3.1 Pfizer Company Details
13.3.2 Pfizer Business Overview
13.3.3 Pfizer Opioid Induced Constipation Treatment Introduction
13.3.4 Pfizer Revenue in Opioid Induced Constipation Treatment Business (2015-2020)
13.3.5 Pfizer Recent Development
13.4 S.L.A. Pharma
13.4.1 S.L.A. Pharma Company Details
13.4.2 S.L.A. Pharma Business Overview
13.4.3 S.L.A. Pharma Opioid Induced Constipation Treatment Introduction
13.4.4 S.L.A. Pharma Revenue in Opioid Induced Constipation Treatment Business (2015-2020)
13.4.5 S.L.A. Pharma Recent Development
13.5 AIKO Biotechnology
13.5.1 AIKO Biotechnology Company Details
13.5.2 AIKO Biotechnology Business Overview
13.5.3 AIKO Biotechnology Opioid Induced Constipation Treatment Introduction
13.5.4 AIKO Biotechnology Revenue in Opioid Induced Constipation Treatment Business (2015-2020)
13.5.5 AIKO Biotechnology Recent Development
13.6 Cubist Pharmaceuticals
13.6.1 Cubist Pharmaceuticals Company Details
13.6.2 Cubist Pharmaceuticals Business Overview
13.6.3 Cubist Pharmaceuticals Opioid Induced Constipation Treatment Introduction
13.6.4 Cubist Pharmaceuticals Revenue in Opioid Induced Constipation Treatment Business (2015-2020)
13.6.5 Cubist Pharmaceuticals Recent Development
13.7 Salix Pharmaceuticals
13.7.1 Salix Pharmaceuticals Company Details
13.7.2 Salix Pharmaceuticals Business Overview
13.7.3 Salix Pharmaceuticals Opioid Induced Constipation Treatment Introduction
13.7.4 Salix Pharmaceuticals Revenue in Opioid Induced Constipation Treatment Business (2015-2020)
13.7.5 Salix Pharmaceuticals Recent Development
13.8 Takeda Pharmaceutical
13.8.1 Takeda Pharmaceutical Company Details
13.8.2 Takeda Pharmaceutical Business Overview
13.8.3 Takeda Pharmaceutical Opioid Induced Constipation Treatment Introduction
13.8.4 Takeda Pharmaceutical Revenue in Opioid Induced Constipation Treatment Business (2015-2020)
13.8.5 Takeda Pharmaceutical Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Opioid Induced Constipation Treatment Revenue
1.4 Market by Type
1.4.1 Global Opioid Induced Constipation Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Oral
1.4.3 Parenteral (Subcutaneous Injection)
1.5 Market by Application
1.5.1 Global Opioid Induced Constipation Treatment Market Share by Application: 2020 VS 2026
1.5.2 Drug Store
1.5.3 Independent Pharmacies
1.5.4 Hospital Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Opioid Induced Constipation Treatment Market Perspective (2015-2026)
2.2 Global Opioid Induced Constipation Treatment Growth Trends by Regions
2.2.1 Opioid Induced Constipation Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Opioid Induced Constipation Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Opioid Induced Constipation Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Opioid Induced Constipation Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Opioid Induced Constipation Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Opioid Induced Constipation Treatment Players by Market Size
3.1.1 Global Top Opioid Induced Constipation Treatment Players by Revenue (2015-2020)
3.1.2 Global Opioid Induced Constipation Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Opioid Induced Constipation Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Opioid Induced Constipation Treatment Market Concentration Ratio
3.2.1 Global Opioid Induced Constipation Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Opioid Induced Constipation Treatment Revenue in 2019
3.3 Opioid Induced Constipation Treatment Key Players Head office and Area Served
3.4 Key Players Opioid Induced Constipation Treatment Product Solution and Service
3.5 Date of Enter into Opioid Induced Constipation Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Opioid Induced Constipation Treatment Historic Market Size by Type (2015-2020)
4.2 Global Opioid Induced Constipation Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Opioid Induced Constipation Treatment Market Size by Application (2015-2020)
5.2 Global Opioid Induced Constipation Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Opioid Induced Constipation Treatment Market Size (2015-2020)
6.2 Opioid Induced Constipation Treatment Key Players in North America (2019-2020)
6.3 North America Opioid Induced Constipation Treatment Market Size by Type (2015-2020)
6.4 North America Opioid Induced Constipation Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Opioid Induced Constipation Treatment Market Size (2015-2020)
7.2 Opioid Induced Constipation Treatment Key Players in Europe (2019-2020)
7.3 Europe Opioid Induced Constipation Treatment Market Size by Type (2015-2020)
7.4 Europe Opioid Induced Constipation Treatment Market Size by Application (2015-2020)
8 China
8.1 China Opioid Induced Constipation Treatment Market Size (2015-2020)
8.2 Opioid Induced Constipation Treatment Key Players in China (2019-2020)
8.3 China Opioid Induced Constipation Treatment Market Size by Type (2015-2020)
8.4 China Opioid Induced Constipation Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Opioid Induced Constipation Treatment Market Size (2015-2020)
9.2 Opioid Induced Constipation Treatment Key Players in Japan (2019-2020)
9.3 Japan Opioid Induced Constipation Treatment Market Size by Type (2015-2020)
9.4 Japan Opioid Induced Constipation Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Opioid Induced Constipation Treatment Market Size (2015-2020)
10.2 Opioid Induced Constipation Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Opioid Induced Constipation Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Opioid Induced Constipation Treatment Market Size by Application (2015-2020)
11 India
11.1 India Opioid Induced Constipation Treatment Market Size (2015-2020)
11.2 Opioid Induced Constipation Treatment Key Players in India (2019-2020)
11.3 India Opioid Induced Constipation Treatment Market Size by Type (2015-2020)
11.4 India Opioid Induced Constipation Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Opioid Induced Constipation Treatment Market Size (2015-2020)
12.2 Opioid Induced Constipation Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Opioid Induced Constipation Treatment Market Size by Type (2015-2020)
12.4 Central & South America Opioid Induced Constipation Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 GlaxoSmithKline
13.1.1 GlaxoSmithKline Company Details
13.1.2 GlaxoSmithKline Business Overview
13.1.3 GlaxoSmithKline Opioid Induced Constipation Treatment Introduction
13.1.4 GlaxoSmithKline Revenue in Opioid Induced Constipation Treatment Business (2015-2020))
13.1.5 GlaxoSmithKline Recent Development
13.2 AstraZeneca
13.2.1 AstraZeneca Company Details
13.2.2 AstraZeneca Business Overview
13.2.3 AstraZeneca Opioid Induced Constipation Treatment Introduction
13.2.4 AstraZeneca Revenue in Opioid Induced Constipation Treatment Business (2015-2020)
13.2.5 AstraZeneca Recent Development
13.3 Pfizer
13.3.1 Pfizer Company Details
13.3.2 Pfizer Business Overview
13.3.3 Pfizer Opioid Induced Constipation Treatment Introduction
13.3.4 Pfizer Revenue in Opioid Induced Constipation Treatment Business (2015-2020)
13.3.5 Pfizer Recent Development
13.4 S.L.A. Pharma
13.4.1 S.L.A. Pharma Company Details
13.4.2 S.L.A. Pharma Business Overview
13.4.3 S.L.A. Pharma Opioid Induced Constipation Treatment Introduction
13.4.4 S.L.A. Pharma Revenue in Opioid Induced Constipation Treatment Business (2015-2020)
13.4.5 S.L.A. Pharma Recent Development
13.5 AIKO Biotechnology
13.5.1 AIKO Biotechnology Company Details
13.5.2 AIKO Biotechnology Business Overview
13.5.3 AIKO Biotechnology Opioid Induced Constipation Treatment Introduction
13.5.4 AIKO Biotechnology Revenue in Opioid Induced Constipation Treatment Business (2015-2020)
13.5.5 AIKO Biotechnology Recent Development
13.6 Cubist Pharmaceuticals
13.6.1 Cubist Pharmaceuticals Company Details
13.6.2 Cubist Pharmaceuticals Business Overview
13.6.3 Cubist Pharmaceuticals Opioid Induced Constipation Treatment Introduction
13.6.4 Cubist Pharmaceuticals Revenue in Opioid Induced Constipation Treatment Business (2015-2020)
13.6.5 Cubist Pharmaceuticals Recent Development
13.7 Salix Pharmaceuticals
13.7.1 Salix Pharmaceuticals Company Details
13.7.2 Salix Pharmaceuticals Business Overview
13.7.3 Salix Pharmaceuticals Opioid Induced Constipation Treatment Introduction
13.7.4 Salix Pharmaceuticals Revenue in Opioid Induced Constipation Treatment Business (2015-2020)
13.7.5 Salix Pharmaceuticals Recent Development
13.8 Takeda Pharmaceutical
13.8.1 Takeda Pharmaceutical Company Details
13.8.2 Takeda Pharmaceutical Business Overview
13.8.3 Takeda Pharmaceutical Opioid Induced Constipation Treatment Introduction
13.8.4 Takeda Pharmaceutical Revenue in Opioid Induced Constipation Treatment Business (2015-2020)
13.8.5 Takeda Pharmaceutical Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
